New Lupus Genes Identified
WEDNESDAY, April 4 (HealthDay News) -- Three new genes linked to
the chronic autoimmune disease lupus have been identified by an
international team of researchers.
HPV-Related Head, Neck Cancers on the Rise
WEDNESDAY, April 4 (HealthDay News) -- The incidence of head and
neck cancers related to the human papillomavirus (HPV) is rising in
the United States, with the greatest increase among middle-aged
white men, a new study finds.
Physician Groups Call for Fewer Medical Tests
WEDNESDAY, April 4 (HealthDay News) -- Nine physician specialty
groups have created lists of common tests or procedures that they
believe are often overused or unnecessary, to help doctors and
patients make wiser decisions about care.
Better Safeguards Needed for Imported Food, Drugs: Report
WEDNESDAY, April 4 (HealthDay News) -- A new report urges the
U.S. Food and Drug Administration (FDA) and other government
agencies to play a stronger part in poor countries to ensure the
safety of food and medications coming into the United States.
Doctors Detail High Costs of Fighting Malpractice Claims
WEDNESDAY, April 4 (HealthDay News) -- For doctors defending
medical malpractice claims, costs vary widely across specialties
and can run into the tens of thousands, even when a patient did not
receive a payout, new research shows.
Berries, Tea May Cut Men's Odds for Parkinson's: Study
WEDNESDAY, April 4 (HealthDay News) -- Regularly consumption of
food and drink rich in substances called flavonoids, such as
berries, apples, tea and red wine, can lower a man's risk of
developing Parkinson's disease by 40 percent, new research
More Fake Avastin Found in U.S., FDA Says
WEDNESDAY, April 4 (HealthDay News) -- The U.S. Food and Drug
Administration says it has confirmed another counterfeit version of
the cancer drug bevacizumab, most commonly known as Avastin, is
being sold in the United States.
Depo-Provera Birth Control Might Raise Breast Cancer Risk
WEDNESDAY, April 4 (HealthDay News) -- There appears to be a
link between an injectable form of progestin-only birth control,
best known as Depo-Provera, and an increased risk of breast cancer
in young women, new research suggests.